A comparative study of the COVID-19 vaccine efficacy among cancer patients: mRNA versus non-mRNA.
PloS one（2023）
摘要
Generally, mRNA vaccines produced significantly higher anti-SARS-CoV-2 S-RBD IgG and NAb levels than non-mRNA vaccines in cancer subjects.
更多查看译文
关键词
vaccine,cancer patients,efficacy,non-mrna
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要